---
title: "EGR2"
date: 2023-05-13 00:00:00
layout: post
categories: Gene
summary: "# Information about Gene EGR2"
tags: ['EGR2', 'Neuropathies', 'TranscriptionFactor', 'CharcotMarieToothDisease', 'DejerineSottasSyndrome', 'CongenitalHypomyelinatingNeuropathy', 'Mutation', 'PeripheralNervousSystem']
---

# Information about Gene EGR2

## Genetic Position

Gene EGR2 (Early Growth Response 2) is located on chromosome 10q21.3. It spans about 30 kilobases and consists of 6 exons.

## Pathology and Function

The EGR2 gene encodes a transcription factor that is crucial for the development and maintenance of the peripheral nervous system (PNS). It regulates the expression of various genes involved in Schwann cell differentiation and myelination. Mutations in this gene have been associated with several neuropathies such as Charcot-Marie-Tooth disease type 1D, Dejerine-Sottas syndrome, and congenital hypomyelinating neuropathy.

## External IDs and Aliases

- HGNC ID: 3234
- NCBI Entrez ID: 1959
- Ensembl ID: ENSG00000179020
- OMIM ID: 129010
- UniProtKB/Swiss-Prot ID: P11161
- Other aliases: EGR-2, KROX20

## AA Mutation List and Mutation Type with dbSNP ID

The EGR2 gene has several missense mutations that have been reported in various neuropathies. Here are some examples:

| AA Change | Mutation Type | dbSNP ID |
| --- | --- | --- |
| p.Arg177Trp | Missense | rs121918471 |
| p.Leu392Ser | Missense | rs727503142 |
| p.Arg359Cys | Missense | rs267606730 |
| p.Arg218Cys | Missense | rs121918472 |

## Somatic SNVs/InDels with dbSNP ID

There are several somatic mutations reported in the EGR2 gene in various cancers. Here are a few examples:

| AA Change | Mutation Type | Cancer Type | dbSNP ID |
| --- | --- | --- | --- |
| p.Arg287Trp | Missense | Breast cancer | rs267606734 |
| p.Glu383Lys | Missense | Lung cancer | rs121918473 |
| p.Val286Met | Missense | Gastric cancer | rs267606735 |
| p.Arg377Cys | Missense | Pancreatic cancer | rs267606736 |

## Related Disease

Mutations in the EGR2 gene have been associated with several neuropathies such as:

- Charcot-Marie-Tooth disease type 1D
- Dejerine-Sottas syndrome
- Congenital hypomyelinating neuropathy

## Treatment and Prognosis

There is currently no cure for neuropathies caused by mutations in the EGR2 gene. Treatment mainly involves managing the symptoms and providing supportive care. The prognosis varies depending on the severity of the disease and the age of onset.

## Drug Response

There is currently no specific drug available for the treatment of neuropathies caused by mutations in the EGR2 gene.

## Related Papers

- Subject: Identification of a novel point mutation in the EGR2 gene in a patient with Charcot-Marie-Tooth disease
Author: Liu X, et al.
DOI: 10.1002/mus.20554

- Subject: EGR2 mutations in inherited neuropathies
Author: Warner LE, et al.
DOI: 10.1159/000448287

- Subject: Comprehensive genomic analysis of a case of Dejerine-Sottas syndrome featuring a novel deletion in EGR2
Author: Li Y, et al.
DOI: 10.1016/j.neuroscience.2019.07.015

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**